M. E. Garza's  Instablog

M. E. Garza
Send Message
M.E. Garza is one of the founders of the biotech and healthcare sector news portal BioMedReports.com. He believes in getting the news from credible sources on the street and often reaches out to CEOs and newsmakers directly for interviews and discussions about their companies. Since he began... More
My company:
My blog:
Daily Info Feeds and Updates
  • RxNews Recap for Tuesday 11-10-09 3 comments
    Nov 11, 2009 2:58 PM | about stocks: AKRX, ALXN, ARQL, IPXL, SNTS, IMGN, TEVA

    Below is a list of the healthcare sector companies that made news in the healthcare sector on Tuesday, November 10, 2009. This list feature is meant to help investors keep tabs on the sector without having to scour through all the press releases.

    Akorn, Inc. (NASDAQ:AKRX) a specialty pharmaceutical company, reported financial results for the third quarter ended September 30, 2009.

    Allos Therapeutics, Inc. (NASDAQ:ALTH), a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics announced management will present at two upcoming conferences: the Lazard Capital Markets 6th Annual Healthcare Conference and the Windhover Therapeutic Area Partnerships event, where the Company’s Pralatrexate for Peripheral T-cell Lymphoma project was named as one of Windhover’s Top 10 interesting oncology projects.

    ArQule, Inc. (Nasdaq:ARQL)
    announced it will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009 at 5:10 p.m. eastern time.

    Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) announced researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (NYSE:ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.

    Biogen Idec Inc. (NASDAQ:BIIB) announced its presentation at the Lazard Capital Markets 6th Annual Healthcare Conference will be webcast live, via the internet, on Tuesday, November 17, 2009 at 10:55a.m. EST.

    Elan Corporation, plc (NYSE:ELN) announced it will present at the Lazard Capital Markets 6th Annual Healthcare Conference, on Tuesday, November 17, 2009 at; 9:55 a.m. Eastern Time and 2:55 p.m. GMT.

    Genoptix, Inc. (Nasdaq:GXDX), a specialized laboratory services provider, announced the Company's participation at the Lazard Capital ManaGement 6th Annual Healthcare Conference at The St. Regis Hotel in New York City on November 17-18, 2009.

    Impax Laboratories, Inc. (NASDAQ:IPXL) announced the Company will present at the Credit Suisse 18th Annual Healthcare Conference on Friday, November 13th, at 10:00 a.m. Mountain Standard time.

    ImmunoGen, Inc. (Nasdaq:IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, announced several ImmunoGen poster presentations will be made at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held in Boston, MA, on November 15-19, 2009.

    The positive mix lift expected as farmers choose to upgrade to next-generation technologies allows Monsanto Company (NYSE:MON) to reconfirm its commitment to double its 2007 gross profit in 2012, Monsanto President and CEO Hugh Grant will tell investors.

    Santarus, Inc. (NASDAQ:SNTS), a specialty biopharmaceutical company, announced Gerald T. Proehl, president and chief executive officer, will make a presentation at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009, at 10:55 a.m. Eastern time (7:55 a.m. Pacific time) at the St. Regis Hotel in New York City.

    S3 Investment Company, Inc. (OTC:SIVC) announced the company's wholly owned Redwood Capital subsidiary has received payment valued at over $500,000 in the form of cash and stock from the recent closing of a client equity offering.

    Sigma-Aldrich® (Nasdaq:SIAL) announced it has entered into an exclusive worldwide distribution agreement with Stemgent, Inc. to offer Stemgent's portfolio of lentivirus-based delivery systems for the generation of induced pluripotent stem (iPS) cells.

    Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (NASDAQ:ANDA) to market its generic version of Takeda Pharmaceuticals North America, Inc.'s Prevacid® (Lansoprazole) SoluTab.

    Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Tap Pharmaceutical's proton pump inhibitor Prevacid® (lansoprazole) Delayed-Release Capsules, 15 mg and 30 mg. Customers will begin receiving product on November 11, 2009.

    Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) announced holders of its 4.75% Convertible Senior Subordinated Notes due 2013 have agreed to exchange approximately $109.0 million in aggregate principal amount of those notes and accrued interest for approximately 4.8 million shares of the Company’s common stock, which is approximately 140,000 shares more than the number of shares into which the notes were convertible under their original terms.

Back To M. E. Garza's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (3)
Track new comments
  • Mayascribe
    , contributor
    Comments (11198) | Send Message
    M.E.Garza: Thanks for the undate.


    Question: Are you aware that right here on SA someone is doing an incredible job concentrating all news about H1N1? This not only includes lots of press releases, listings of all stocks, global news, maps, and analytics on some swine flu stocks. A huge wealth of information.




    Highly recommend you look into his work and add him to your following list.


    To get to the "Swine Flu Concentrater Part 3," click below:


    11 Nov 2009, 04:40 PM Reply Like
  • Mayascribe
    , contributor
    Comments (11198) | Send Message
    Oops! please white out, "...not only," in the above comment.
    11 Nov 2009, 04:41 PM Reply Like
  • M. E. Garza
    , contributor
    Comments (122) | Send Message
    Author’s reply » Thanks for the heads up. Just added him/her to my list!
    12 Nov 2009, 04:01 AM Reply Like
Full index of posts »
Latest Followers


  • Hearing some interesting developments on the horizon for $NWBO. Did an article on them yesterday. Looks promising. http://bit.ly/NWBOnews
    Jul 12, 2011
  • ($RXPC.PK 3 of 3) If it were bad news, chances are they'd have something by now, since delisting decisions are usually handed down quickly.
    Apr 19, 2011
  • ($RXPC.PK 2 of 3) a listing extension would go until July [when the stock would have to be over $1 to continue being listed on Amex].
    Apr 19, 2011
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.